Trenkwalder, Peter
Patients with type 2 diabetes and chronic kidney disease who received semaglutide in the historic FLOW trial had a 20% lower risk of dying from any cause and a 24% lower risk of significant renal events, such as dialysis, transplant, or kidney-related death
(system supported by DigitalSiber.id)
The term had circulated in patient communities and across TikTok for years, but it reached a mass audience in 2024, when Oprah Winfrey devoted a primetime special, "Shame, Blame and the Weight Loss Revolution," to weight-loss medications and spoke candidly about how they quieted her own food noise
CJC1295 and Ipamorelin also work to increase growth hormones
Heres what you and your team should know: To view or add a comment, sign in Why are peptides still have such unclear regulations